Calcium and vitamin D supplementation with 3-year denosumab treatment is beneficial to enhance bone mineral density in postmenopausal patients with osteoporosis and rheumatoid arth...

by Suzuki T, Nakamura Y, Kato H
Published 2018-12-01

Serum bone alkaline phosphatase is a useful marker to evaluate lumbar bone mineral density in Japanese postmenopausal osteoporotic women during denosumab treatment

by Nakamura Y, Suzuki T, Kato H
Published 2017-10-01

Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis

by Suzuki T, Nakamura Y, Kato H
Published 2018-03-01

Adequate nutrition status important for bone mineral density improvement in a patient with anorexia nervosa

by Nakamura Y, Kamimura M, Koiwai H, Kato H
Published 2018-05-01

Efficacy of denosumab in two cases with multiple-system atrophy and osteoporosis

by Uehara M, Nakamura Y, Takahashi J, Suzuki T, Kato H
Published 2018-05-01

Short-term bisphosphonate treatment reduces serum 25(OH) vitamin D3 and alters values of parathyroid hormone, pentosidine, and bone metabolic markers

by Kamimura M, Uchiyama S, Nakamura Y, Ikegami S, Mukaiyama K, Kato H
Published 2017-02-01

Significant improvement of bone mineral density by denosumab treatment in Japanese osteoporotic patients following breast cancer treatment

by Nakamura Y, Kamimura M, Morikawa A, Taguchi A, Suzuki T, Kato H
Published 2018-03-01

Pre-treatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy

by Kamimura M, Taguchi A, Nakamura Y, Koiwai H, Ikegami S, Uchiyama S, Kato H
Published 2018-04-01

A case series of pregnancy- and lactation-associated osteoporosis and a review of the literature

by Nakamura Y, Kamimura M, Ikegami S, Mukaiyama K, Komatsu M, Uchiyama S, Kato H
Published 2015-09-01

Open-label Phase II study of everolimus plus endocrine therapy in postmenopausal women with ER-positive and HER2-negative metastatic breast cancer (Chloe trial)

by Shimoi T, Shimomura A, Shien T, Uemura Y, Kato H, Kitada M, Toyama T, Aihara T, Mukai H
Published 2018-02-01

Efficacy of denosumab therapy for a 21-year-old woman with Prader-Willi syndrome, osteoporosis and history of fractures: a case report

by Uehara M, Nakamura Y, Takahashi J, Suzuki T, Iijima M, Arakawa Y, Ida K, Kosho T, Kato H
Published 2019-02-01

Efficacy of denosumab therapy for neurofibromatosis type I with osteoporosis and history of fractures: a case report

by Uehara M, Nakamura Y, Takahashi J, Kamimura M, Isobe F, Yamaguchi T, Kosho T, Uchiyama S, Suzuki T, Kato H
Published 2018-07-01

The association of sleep quality with dry eye disease: the Osaka study

by Kawashima M, Uchino M, Yokoi N, Uchino Y, Dogru M, Komuro A, Sonomura Y, Kato H, Kinoshita S, Tsubota K
Published 2016-06-01

Temperature dependence of interlayer coupling in perpendicular magnetic tunnel junctions with GdO X barriers

by Newhouse-Illige, T., Xu, Y. H., Liu, Y. H., Huang, S., Kato, H., Bi, C., Xu, M., LeRoy, B. J., Wang, W. G.
Published 2018

Biological responses according to the shape and size of carbon nanotubes in BEAS-2B and MESO-1 cells

by Haniu H, Saito N, Matsuda Y, Tsukahara T, Usui Y, Maruyama K, Takanashi S, Aoki K, Kobayashi S, Nomura H, Tanaka M, Okamoto M, Kato H
Published 2014-04-01